Pathology To Accelerated Cognitive Decline In Parkinson's Patients
17/11/2025 13:04
Annovis Bio Inc ANVS.N: ANNOVIS REPORTS NEW BIOMARKER DATA LINKING AMYLOID CO-PATHOLOGY TO ACCELERATED COGNITIVE DECLINE IN PARKINSON'S PATIENTS ANNOVIS BIO INC - BUNTANETAP IMPROVES COGNITION IN PARKINSON'S WITH AMYLOID CO-PATHOLOGY Source text: ID:nGNX7Sr0tt Further company coverage: ANVS.N
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman